NAT2 and acute lymphoblastic leukemia: However, Kamel et al., (2015) reported that NAT2*5B (314T>C, 481C>T and 803A>G) & *5C (314T>C,803A>G) were associated with a decreased risk of ALL development, giving 1.8 and 2.4-fold protection, respectively.